Prazosin

Source: Wikipedia, the free encyclopedia.

Prazosin
prazosin 2D skeletal
prazosin 3D BS
Clinical data
Trade namesMinipress, others
AHFS/Drugs.comMonograph
MedlinePlusa682245
License data
Pregnancy
category
Routes of
administration
By mouth
Drug classα1 blocker
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability~60%
Protein binding97%[4]
Onset of action30–90 minutes[5]
Elimination half-life2–3 hours[4]
Duration of action10–24 hours[4]
Identifiers
  • [4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2-furyl)methanone
JSmol)
  • O=C(N3CCN(c2nc1cc(OC)c(OC)cc1c(n2)N)CC3)c4occc4
  • InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22) checkY
  • Key:IENZQIKPVFGBNW-UHFFFAOYSA-N checkY
  (verify)

Prazosin, sold under the brand name Minipress among others, is a

enlarged prostate, and nightmares related to post-traumatic stress disorder (PTSD).[6] It is an α1 blocker.[6] It is a less preferred treatment of high blood pressure.[6] Other uses may include heart failure and Raynaud syndrome.[7] It is taken by mouth.[6]

Common

blood vessels and helps with an enlarged prostate by relaxing the outflow of the bladder.[6] How it works in PTSD is not entirely clear.[6]

Prazosin was patented in 1965 and came into medical use in 1974.

generic medication.[6] In 2021, it was the 183rd most commonly prescribed medication in the United States, with more than 2 million prescriptions.[9][10]

Medical uses

Prazosin is active after taken by mouth and has a minimal effect on cardiac function due to its

α1-adrenergic receptor selectivity. When prazosin is started, however, heart rate and contractility can increase in order to maintain the pre-treatment blood pressures because the body has reached homeostasis
at its abnormally high blood pressure. The blood pressure lowering effect becomes apparent when prazosin is taken for longer periods of time. The heart rate and contractility go back down over time and blood pressure decreases.

The antihypertensive characteristics of prazosin make it a second-line choice for the treatment of high blood pressure.[11]

Prazosin is also useful in treating urinary hesitancy associated with benign prostatic hyperplasia, blocking α1-adrenergic receptors, which control constriction of both the prostate and urethra. Although not a first-line choice for either hypertension or benign prostatic hyperplasia, it is a choice for people who present with both problems concomitantly.[11]

During its use for urinary hesitancy in military veterans in the 1990s, Murray A. Raskind and colleagues discovered that prazosin appeared to be effective in reducing nightmares. Subsequent reviews indicate prazosin is effective in improving sleep quality and treating nightmares related to post-traumatic stress disorder (PTSD).[12][13]

Prazosin is used off-label in the treatment of insomnia and can produce sedative effects.[14][15]

The drug is usually recommended for severe stings from the

Indian red scorpion.[16][17][18]

Adverse effects

Common (4–10% frequency) side effects of prazosin include

first dose response", in which the side effects of the drug — specifically orthostatic hypotension, dizziness, and drowsiness — are especially pronounced in the first dose.[3]

Orthostatic hypotension and syncope are associated with the body's poor ability to control blood pressure without active α-adrenergic receptors. The nasal congestion is exacerbated by changing body positions, because α1-adrenergic receptors also control nasal vascular blood flow and alpha blockers inhibit this, in the same way that alpha-adrenergic agonists have the opposite effect of being a decongestant.[20][21]

Pharmacology

Pharmacodynamics

Prazosin is an

immune cells, where catecholamine binding can stimulate and enhance cytokine production.[27][28]

Pharmacokinetics

Prazosin has an

duration of action is 10 to 24 hours.[4]

Research

Prazosin has been said to be the only selective α1-adrenergic receptor antagonist which has been used in the treatment of insomnia to any significant degree.[14] It is used at doses of 1 to 12 mg for this purpose.[14] The combination of prazosin and the beta blocker timolol may produce greater sedative effects than either of them alone.[15]

Prazosin has been shown to prevent death in animal models of

COVID-19 where it is thought to decrease cytokine dysregulation.[30][28][31]

References

  1. ^ "Prazosin (Minipress) Use During Pregnancy". Drugs.com. 26 November 2019. Retrieved 30 January 2020.
  2. ^ "Hypovase Tablets 0.5mg - Summary of Product Characteristics (SmPC)". (emc). 26 April 2021. Retrieved 5 February 2023.
  3. ^ a b c d e "Minipress- prazosin hydrochloride capsule". DailyMed. 19 July 2021. Retrieved 5 February 2023.
  4. ^ a b c d e "Prazosin". drugs.com. Retrieved 15 March 2020.
  5. ^
    PMID 761333
    .
  6. ^ a b c d e f g h i j "Prazosin Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 18 March 2019.
  7. ^ .
  8. .
  9. ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  10. ^ "Prazosin - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
  11. ^ .
  12. .
  13. .
  14. ^ .
  15. ^ .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. .
  22. ^ "Prazosin: Biological activity". IUPHAR. International Union of Basic and Clinical Pharmacology. Retrieved 3 June 2016.
  23. ^ a b "Prazosin". DrugBank.
  24. ^ a b "Prazosin Ligand page". IUPHAR/BPS Guide to PHARMACOLOGY.
  25. ^ "Prazosin: Clinical data". IUPHAR. International Union of Basic and Clinical Pharmacology. Retrieved 3 June 2016. This sympatholytic drug is used in the treatment of hypertension, anxiety and post-traumatic stress disorder. ... Antagonist of alpha-1 adrenoceptors on vascular smooth muscle, thereby inhibiting the vasoconstrictor effect of circulating and locally-released adrenaline and noradrenaline, resulting in peripheral vasodilation.
  26. S2CID 28007564
    .
  27. .
  28. ^ .
  29. .
  30. ^ "Preventing 'Cytokine Storm' May Ease Severe COVID-19 Symptoms". HHMI.org. Retrieved 24 May 2020.
  31. ^ Clinical trial number NCT04365257 for "Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) (PREVENT)" at ClinicalTrials.gov